Share

Search your stocks

Ctrl+K

BAFNAPHBafna Pharmaceuticals Ltd.

156.03(-2.00%)

1W: -9.66%

1M: +60.36%

1Y: +85.14%

Bafna Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue growth reflects strong demand despite market conditions.
Operating profit margin at 28.13% indicates efficient cost management.
Net profit of ₹0.60 crore demonstrates profitability in challenging times.

NEGATIVES

Expenses at ₹9.44 crore are high relative to revenue.
Negative other income suggests lack of additional revenue streams.
High tax rate of 72.32% may impact overall profitability.

Quarterly Results Data (Numbers are in Crore)

Field	Trend	Mar 20
Revenue	-	13.13
Expenses	-	9.44
Operating Profit	-	3.69
Other Income	-	-0.67
Interest	-	0.03
Depreciation	-	0.53
Profit Before Tax	-	2.18
Tax	-	1.58
Net Profit	-	0.60
Eps in Rs	-	0.20